Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech ranked by P/S ratio, at 3.8, followed by Qiagen (4.9) and Neurocrine Biosciences (5.9). Figures as of 18 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.8
Median
14.5
Combined market value
CHF 713.7B
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.8CHF 31.3BCHF 211.96 0.41% up 49% up United States
2QiagenQGEN · Health Care4.9CHF 8.6BCHF 41.85 0.06% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.9CHF 14.1BCHF 139.39 0.19% down 20% up United States
4BioNTechBNTX · Health Care6.6CHF 17.8BCHF 71.64 0.30% up 16% down Germany
5AmgenAMGN · Health Care6.7CHF 206.2BCHF 381.19 1.10% down 34% up United States
6Gilead SciencesGILD · Health Care7.1CHF 177.1BCHF 142.82 0.34% down 33% up United States
7ExelixisEXEL · Health Care7.2CHF 14.1BCHF 57.72 0.11% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9CHF 9.2BCHF 80.99 0.27% up 37% up United States
9Bio-TechneTECH · Health Care9.4CHF 9.6BCHF 61.21 0.13% up 26% up United States
10argenxARGX · Health Care14.5CHF 50.8BCHF 808.20 1.34% up 4% up Belgium
11RepligenRGEN · Health Care14.7CHF 9.2BCHF 143.16 4.87% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care16.8CHF 3.9BCHF 24.21 0.95% up 88% up United States
13Twist BioscienceTWST · Health Care20.5CHF 6.5BCHF 95.38 1.18% up 340% up United States
14Krystal BiotechKRYS · Health Care23.0CHF 7.5BCHF 254.58 1.31% up 46% up United States
15ModernaMRNA · Health Care43.2CHF 70.6BCHF 174.59 0.30% up 755% up United States
16ImmunityBioIBRX · Health Care58.4CHF 5.6BCHF 5.24 0.64% down 193% up United States
17Kymera TherapeuticsKYMR · Health Care267CHF 8.8BCHF 103.34 1.03% up 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1161CHF 3.4BCHF 35.35 4.60% up 21% down Switzerland
19CG OncologyCGON · Health Care1755CHF 6BCHF 66.81 0.56% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8417 CHF). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/S ratio?

Biogen (3.8), Qiagen (4.9) and Neurocrine Biosciences (5.9) have the lowest P/S ratio of the 19 biotech ranked here as of 18 Nov 2026, 14:43 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of CHF 713.7B as of 18 Nov 2026, 14:43 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.